Data for Good

We place great importance on using innovative approaches in our business and in our AI to drive true commercial and societal benefit.

By prioritising ESG factors, we believe we are driving innovation that addresses global and social challenges.

We aspire to contribute positively to our communities, aligning with the evolving expectations of stakeholders and investors.

We are constantly learning from, and fortunate to benefit from, the experience of others to refine our practices and operations, as well as giving back to take others forward.

Talking Medicines prioritises environmental responsibility to contribute toward sustainability and mitigate climate risks, and aims to align with the growing awareness of eco-conscious practices alongside our stakeholder partners.

We recognise the importance of good environmental practice and understand that it is crucial for ethical business conduct.

Integrating finance into our ESG framework enhances our corporate reputation and attracts socially responsible investors and partners.

It fosters sustainable and responsible business practices across everything we fund and build.

Strong governance practices not only safeguard against potential risks but also ensure transparent communication with stakeholders, reinforcing our commitment to social responsibility.

Effective governance is integral to building resilience, maintaining trust, and fostering sustainable business practices.

Impact refers to the measurable and often transformative effects that an action, initiative, or entity has on society, the environment, or the economy.

Talking Medicines has a strategy on social impact that includes the key team, community, and stakeholder partners, including Patients and Patient organisations.